ARKG

ARKG
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that seeks long-term growth of capital by investing at least 80% of its assets in domestic and foreign equity securities relevant to the genomics revolution.
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that seeks long-term growth of capital by investing at least 80% of its assets in domestic and foreign equity securities relevant to the genomics revolution.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
CRSP | CRISPR Therapeutics AG | 10.06% | 2.00M | $109.91M |
TWST | Twist Bioscience Corporation | 9.08% | 1.97M | $99.21M |
TEM | Tempus AI, Inc. | 8.38% | 1.99M | $91.59M |
TXG | 10x Genomics, Inc. | 6.62% | 3.07M | $72.35M |
BEAM | Beam Therapeutics Inc. | 5.82% | 2.11M | $63.62M |
PSNL | Personalis, Inc. | 4.40% | 7.61M | $48.02M |
NTLA | Intellia Therapeutics, Inc. | 3.77% | 2.88M | $41.13M |
RXRX | Recursion Pharmaceuticals, Inc. | 3.73% | 11.91M | $40.74M |
GH | Guardant Health, Inc. | 3.54% | 470.84K | $38.71M |
CDNA | CareDx, Inc | 3.27% | 2.12M | $35.72M |
VCYT | Veracyte, Inc. | 2.82% | 949.20K | $30.79M |
ADPT | Adaptive Biotechnologies Corporation | 2.61% | 2.02M | $28.48M |
NRIX | Nurix Therapeutics, Inc. | 2.38% | 1.64M | $26.03M |
WGS | GeneDx Holdings Corp. | 2.13% | 380.92K | $23.23M |
SDGR | Schrödinger, Inc. | 2.08% | 1.99M | $22.75M |
ARCT | Arcturus Therapeutics Holdings Inc. | 2.06% | 2.67M | $22.56M |
CMPS | COMPASS Pathways plc | 1.66% | 3.15M | $18.16M |
PRME | Prime Medicine, Inc. | 1.57% | 4.68M | $17.11M |
PACB | Pacific Biosciences of California, Inc. | 1.39% | 10.45M | $15.15M |
MASS | 908 Devices Inc. | 1.22% | 1.85M | $13.34M |
SECTOR HOLDINGS
Healthcare
Financial Services
Cash & OthersASSET ALLOCATION BY REGION
SECTOR HOLDINGS
Healthcare
Financial Services
Cash & OthersASSET ALLOCATION BY REGION
Holdings (Top 20)
CRSP
CRISPR Therapeutics AG
TWST
Twist Bioscience Corporation
TEM
Tempus AI, Inc.
TXG
10x Genomics, Inc.
BEAM
Beam Therapeutics Inc.
PSNL
Personalis, Inc.
NTLA
Intellia Therapeutics, Inc.
RXRX
Recursion Pharmaceuticals, Inc.
GH
Guardant Health, Inc.
CDNA
CareDx, Inc
VCYT
Veracyte, Inc.
ADPT
Adaptive Biotechnologies Corporation
NRIX
Nurix Therapeutics, Inc.
WGS
GeneDx Holdings Corp.
SDGR
Schrödinger, Inc.
ARCT
Arcturus Therapeutics Holdings Inc.
CMPS
COMPASS Pathways plc
PRME
Prime Medicine, Inc.
PACB
Pacific Biosciences of California, Inc.
MASS
908 Devices Inc.
